Responses
Therapeutics
Systematic review
Combination therapy with long-acting β-agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects
Compose a Response to This Article
Other responses
No responses have been published for this article.